The Development of a Screening Tool for the Risk of Hepatotoxicity Prediction in Patients Receiving Anti-tuberculosis Agents - การพัฒนาแบบคัดกรองเพื่อประเมินความเสี่ยงต่อการเกิดพิษต่อตับในผู้ป่วยที่ใช้ยาต้านวัณโรค

Authors

  • Boossakorn Hanwong
  • Parimoke Kerdchantuk
  • Surasak Kasemsiri
  • Anun Chaikoolvatana

Abstract

The purpose of this study was to investigate the incidences and factors affecting the hepatotoxicity
related to anti-tuberculosis agents. The development of a screening tool included the risk factors
of liver toxicity prediction in patients receiving anti-tuberculosis agents.
This research was a two-month prospective cohort study within 5 hospitals in the northeast of
Thailand. This study was conducted from March 2010 to May 2011. Bivariate analysis of each
variable was performed, followed by multivariate analysis of those with statistical significance.
Predictive scores were derived from statistically significant factors at the cut-off point of receiveroperating
curve that yielded the best area under the curve.
The risk factors associated with the hepatotoxicity from binary logistic regression analysis
included age (> 60 years)(OR 2.399,95%CI 1.203,4.784), HIV infection (OR 3.778, 95%CI
1.606,8.888), anemia (OR 2.946, 95%CI 1.312,6.613), low body mass index (<18.5 kg/m2) (OR
2.058, 95%CI 1.106,6.562 ), low serum albumin level (<3.5 mg%) (OR 3.593, 95%CI 1.967,3.828),
and the exposure of other drugs induced hepatotoxicity (OR 2.273, 95%CI 1.104,4.680). By integrating
risk factors into the screening tool, the cut-off point for hepatotoxicity prediction is equally
to 9 (0-24). The sensitivity was 72.73 percent, the specificity was 79.29 percent. The screening tool
for the risk of hepatotoxicity prediction should be performed by the medical staff prior to antituberculosis
treatment. It is recommended that all patients with a score ranging from 9 to 24 points
should be monitored for liver function before and after receiving anti-tuberculosis agent within 4
weeks to prevent the occurrence of severe hepatotoxicity.
Key words: hepatotoxicity, hepatitis, screening tool, anti-tuberculosis agent, risk factor

Downloads

Download data is not yet available.

Published

2017-12-06

How to Cite

Hanwong, B., Kerdchantuk, P., Kasemsiri, S., & Chaikoolvatana, A. (2017). The Development of a Screening Tool for the Risk of Hepatotoxicity Prediction in Patients Receiving Anti-tuberculosis Agents - การพัฒนาแบบคัดกรองเพื่อประเมินความเสี่ยงต่อการเกิดพิษต่อตับในผู้ป่วยที่ใช้ยาต้านวัณโรค. Journal of Health Science of Thailand, 22(3), 454–463. Retrieved from https://thaidj.org/index.php/JHS/article/view/860

Issue

Section

Original Article (นิพนธ์ต้นฉบับ)